货号:A313387 同义名: NSC 41791;NSC 4753
Sulfapyridine is a sulfonamide antibiotic mostly used in treating rheumatoid arthritis and certain skin diseases with potentially toxicity.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Sulfasalazine was the first aminosalicylate to be used for induction and maintenance therapy of ulcerative colitis (UC)[3]. Sulfasalazine is a potent inhibitor of superoxide production and granule enzyme release by stimulated neutrophils, and modulation of these responses may contribute to its anti-inflammatory properties. The inhibitory effects of sulfasalazine on superoxide production, degranulation and neutrophil-mediated collagen degradation were closely mimicked by olsalazine[4]. Sulfasalazine and sulfapyridine but not 5-aminosalicylate inhibit spontaneous cytotoxicity mediated by human natural killer (NK) cells[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01596777 | Intestinal Obstruction | Phase 1 | Completed | - | Germany ... 展开 >> Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald Greifswald, Mecklenburg-Vorpommern, Germany 收起 << |
NCT00637780 | Arthritis, Juvenile Rheumatoid | Phase 4 | Terminated(Study terminated on... 展开 >> 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 << | - | United States, Ohio ... 展开 >> University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Mexico Private Office Guadalajara, Jalisco, Mexico, 44650 收起 << |
NCT01596764 | Intestinal Obstruction | Phase 1 | Completed | - | Germany ... 展开 >> Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald Greifswald, Mecklenburg-Vorpommern, Germany 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.01mL 0.80mL 0.40mL |
20.06mL 4.01mL 2.01mL |
40.11mL 8.02mL 4.01mL |
CAS号 | 144-83-2 |
分子式 | C11H11N3O2S |
分子量 | 249.289 |
别名 | NSC 41791;NSC 4753;Pyriamid;Plurazol;A 499;Sulphapyridine |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
DMSO: 60 mg/mL(240.68 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |